Paul C Trippier, PhD

Associate Professor

  • 531 Citations
  • 12 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Paul C Trippier is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Pyrazolones Medicine & Life Sciences
flupirtine Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
PC12 Cells Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Antineoplastic Agents Medicine & Life Sciences
Boronic Acids Medicine & Life Sciences
Neuronal Ceroid-Lipofuscinoses Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 531 Citations
  • 12 h-Index
  • 23 Article
  • 5 Review article
  • 1 Comment/debate
  • 1 Editorial
2 Citations (Scopus)

Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease

Morsy, A. & Trippier, P. C., May 9 2019, In : Journal of Medicinal Chemistry. 62, 9, p. 4252-4264 13 p.

Research output: Contribution to journalReview article

Alcohol Dehydrogenase
Alzheimer Disease
1 Citation (Scopus)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Protein Isoforms
5 Citations (Scopus)

AKR1C3 inhibitor KV-37 exhibits antineoplastic effects and potentiates enzalutamide in combination therapy in prostate adenocarcinoma cells

Verma, K., Gupta, N., Zang, T., Wangtrakluldee, P., Srivastava, S. K., Penning, T. M. & Trippier, P. C., Sep 2018, In : Molecular cancer therapeutics. 17, 9, p. 1833-1845 13 p.

Research output: Contribution to journalArticle

Open Access
Antineoplastic Agents
Prostatic Neoplasms
1 Citation (Scopus)

DARK Classics in Chemical Neuroscience: Methamphetamine

Abbruscato, T. J. & Trippier, P. C., Oct 17 2018, In : ACS Chemical Neuroscience. 9, 10, p. 2373-2378 6 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Nasal Decongestants
6 Citations (Scopus)

Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses

Makoukji, J., Saadeh, F., Mansour, K. A., El-Sitt, S., Al Ali, J., Kinarivala, N., Trippier, P. C. & Boustany, R. M., Sep 2018, In : Annals of Clinical and Translational Neurology. 5, 9, p. 1089-1103 15 p.

Research output: Contribution to journalArticle

Open Access
Neuronal Ceroid-Lipofuscinoses
PC12 Cells